Trust Signals
Key Takeaways
- FDA-approved Ozempic and Wegovy labeling states explicitly: "Do not freeze. Do not use if it has been frozen." This is a hard discard rule.
- Freezing can cause ice-crystal mechanical disruption and protein aggregation in semaglutide's 39-amino-acid GLP-1 analog structure, including damage to the C18 fatty-acid linker responsible for albumin binding and the drug's roughly 165-hour half-life.
- Potency loss from freezing is not reliably visible to the naked eye. A clear-looking vial can still contain aggregated, under-potent peptide.
- Household refrigerators can freeze product near the back wall or under freezer vents even when the thermostat reads within range. Middle-shelf, front-of-fridge placement is the correct storage position.
- Lyophilized (powder) compounded semaglutide has different stability characteristics than solution, but still requires following the compounding pharmacy's specific label, not a general assumption that powder survives freezing.
Can Semaglutide Freeze? Direct Answer
No, semaglutide solution must not be frozen. The FDA-approved prescribing information for Ozempic and Wegovy carries an explicit "do not freeze" instruction and a discard rule if freezing has occurred. Freezing causes structural damage to the peptide and its albumin-binding fatty-acid chain that cannot be reversed or assessed without laboratory testing. Any frozen vial or pen should be discarded, not used.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of Contents
- What happens to semaglutide if it freezes?
- Evidence ledger: what we know and how confidently
- How can I tell if my semaglutide has been frozen?
- What is the correct storage temperature for semaglutide?
- Why do refrigerators sometimes freeze semaglutide near the back wall?
- What is the chemistry behind why freezing destroys peptides?
- What most pages get wrong about frozen semaglutide
- Does lyophilized (powder) semaglutide behave differently?
- Freezing vs. heat damage: how do they compare?
- Operational checklist: reading labels and handling cold-chain failures
- Frequently asked questions
- Sources
What happens to semaglutide if it freezes?
Semaglutide is a 39-amino-acid GLP-1 receptor agonist analog. Its commercial formulation (Ozempic, Wegovy) is an aqueous solution. When that solution freezes, several damaging events can occur simultaneously:
Ice crystal formation. As water transitions to ice, expanding crystals exert mechanical pressure on dissolved protein molecules. This physical force can unfold or distort the peptide's native conformation.
Concentration effects. As water freezes out of solution, the remaining liquid phase becomes highly concentrated in salts and excipients. Extreme local pH and ionic strength shifts during freezing can accelerate chemical degradation pathways including deamidation and oxidation.
Aggregation. Unfolded or partially denatured peptide chains tend to clump together (aggregate). Aggregates can be sub-visible (not detectable by eye) or visible as cloudiness or particles. Both are problems: sub-visible aggregates can reduce effective dose and raise immunogenicity concerns.
Fatty-acid linker vulnerability. What makes semaglutide distinct from liraglutide is a C18 diacid fatty-acid chain attached via a linker to position 26 lysine. This modification enables reversible albumin binding and extends the half-life to approximately 165 hours. The precise conformation of that linker in aqueous solution is sensitive to freeze-thaw stress. Damage here directly undermines the pharmacokinetics that define semaglutide's once-weekly dosing advantage.
Evidence Ledger: What We Know and How Confidently
| Claim | Best Evidence Type | Direction | Confidence |
|---|---|---|---|
| Freezing causes protein aggregation in peptide/protein biologics generally | Multiple peer-reviewed biopharmaceutics studies; USP guidance | Consistent harm | High |
| FDA labeling prohibits freezing Ozempic and Wegovy | Regulatory label (FDA-approved prescribing information) | Hard discard rule | High |
| Semaglutide's C18 fatty-acid linker is vulnerable to freeze-thaw stress specifically | Mechanistic/structural reasoning from published biologic formulation science; Novo Nordisk patent literature on semaglutide formulation | Plausible harm; specific data not publicly quantified | Moderate |
| Sub-visible aggregates can form without visible cloudiness | Established in protein biologic literature; standard USP 789 concern | Consistent finding in biologics class | High (class-level); Moderate (semaglutide-specific) |
| Frozen-then-thawed semaglutide has meaningfully reduced potency | No published clinical or in vitro study specific to semaglutide; inferred from class evidence | Likely harm; magnitude unknown | Low (semaglutide-specific) |
| Immunogenicity risk increases with frozen/aggregated semaglutide | Mechanistic concern well established for biologics; no semaglutide-specific data | Theoretical risk | Very low (semaglutide-specific) |
| Brief near-freezing exposure causes zero damage | No evidence; not established | Unknown | Very low |
How can I tell if my semaglutide has been frozen?
Visual inspection is a minimum check, not a clearance test. Look for these signs of freezing or freeze-related damage:
- Cloudiness or milkiness: Clear solution that now looks hazy or white suggests particulate formation from aggregation.
- Visible particles: White or translucent flecks that do not dissolve with gentle rotation.
- Color shift: Semaglutide solution should be colorless to slightly yellow. A distinct yellow or amber color shift can indicate degradation.
- Frost residue inside the cap or on the vial neck: A sign the product reached or passed 32 F (0 C).
- Packaging deformation: Expanded or cracked vials in rare severe freeze cases.
What is the correct storage temperature for semaglutide?
| Product Type | Unopened Storage | After First Use | Discard After |
|---|---|---|---|
| Ozempic (pen, 0.25 to 2 mg) | 36 to 46 F (2 to 8 C), refrigerated | Refrigerated OR room temp up to 77 F (25 C) | 56 days after first use |
| Wegovy (pen, 0.25 to 2.4 mg) | 36 to 46 F (2 to 8 C), refrigerated | Refrigerated OR room temp up to 77 F (25 C) | 28 days after first use |
| Compounded semaglutide vial (solution) | Per pharmacy label, typically 36 to 46 F (2 to 8 C) | Per pharmacy label; typically refrigerated throughout | Per pharmacy label (commonly 28 to 30 days) |
| Compounded semaglutide (lyophilized) | Per pharmacy label; often refrigerated; some allow room temp short-term | After reconstitution: typically refrigerated, use within pharmacy-specified window | Per pharmacy label |
All forms share the same floor: do not allow the temperature to drop to or below 32 F (0 C).
Why do refrigerators sometimes freeze semaglutide near the back wall?
This is one of the most practical questions that commodity pages skip entirely.
Household refrigerators maintain average temperatures near the thermostat sensor, but temperature distribution inside the cabinet is uneven. The evaporator coil (the refrigeration element) typically runs along the back wall or under a top freezer compartment. Air near these surfaces can be several degrees colder than the set temperature, sometimes dropping below freezing even when the dial reads a safe 37 to 38 F.
Practical placement rules:
- Store semaglutide on the middle shelf, away from the back wall by at least a few inches.
- Do not store it in the door (too warm, temperature fluctuates with every opening).
- Do not store directly beneath a freezer vent.
- If you suspect your refrigerator runs cold, place a simple refrigerator thermometer near where you store the vial for 24 to 48 hours and confirm it stays between 36 and 46 F consistently.
What is the chemistry behind why freezing destroys peptides?
Understanding the mechanism lets you make better decisions in edge cases rather than just following rules blindly.
The hydrophobic effect and protein folding. Proteins and peptides fold into their functional 3D shape partly because hydrophobic amino-acid side chains prefer the protein interior over contact with water. This folding is driven by entropy of the surrounding water molecules. When water freezes and its hydrogen-bond network becomes rigid ice, it can no longer accommodate the protein-water interface that stabilizes the folded state. The protein is exposed to mechanical stress from ice crystal growth.
Freeze concentration. As ice forms, dissolved solutes (phosphate buffer components, phenol preservative in Ozempic, mannitol or other excipients) are pushed into a shrinking liquid volume. Buffer components can shift pH dramatically during freezing because phosphate salts have different freezing points than water. A pH excursion during freezing promotes deamidation at asparagine and glutamine residues, one of the most common peptide degradation pathways.
Why the C18 linker matters here. Semaglutide's fatty-acid chain is designed to sit against albumin's hydrophobic binding pocket in plasma. This interaction is geometrically specific. Aggregation or conformational change in the peptide backbone during freezing can alter the spatial presentation of that chain, reducing albumin affinity and therefore shortening effective half-life even if the amino-acid sequence is chemically intact.
Why you cannot fix it. Thawing re-dissolves ice but does not re-fold aggregated protein. The folded state requires specific thermodynamic conditions to form spontaneously, and once an aggregate forms, the intermolecular contacts stabilize it. You would need industrial refolding chromatography, chaperones, and subsequent analytical verification to know if the molecule was restored. None of that is possible at home or in a clinic.
What most pages get wrong about frozen semaglutide
Mistake 1: "It looks fine, so it probably is fine." This logic fails for biologics. Sub-visible aggregation is the standard concern in biopharmaceutics precisely because it is invisible. The FDA's answer is not "inspect and decide" but "if frozen, discard." Period.
Mistake 2: Treating lyophilized powder the same as solution. Lyophilization was invented partly to improve freeze-stability of biologics by removing water before freezing. Powder semaglutide is a different product category from solution. But "more stable" does not mean "freeze-safe by default." Each compounding pharmacy's product has its own stability data and label, and that label governs.
Mistake 3: Assuming a brief freeze is a minor event. Duration matters in freezing kinetics, but the critical factor is whether ice formed in the solution, not how long it stayed frozen. A few minutes at well below 32 F can be enough to initiate crystallization and aggregation. There is no published threshold for semaglutide that defines a "safe" freeze duration.
Mistake 4: Confusing the 77 F room-temperature rule with freeze tolerance. Some pages note that Ozempic can be stored at room temperature after first use and infer the product is thermally robust. The room-temperature rule applies to temperatures up to 77 F, not to sub-freezing temperatures. Cold and warm tolerance are independent properties governed by different degradation mechanisms.
Does lyophilized (powder) semaglutide behave differently?
Lyophilized semaglutide, produced by some compounding pharmacies, is freeze-dried to a powder cake. Because free water is largely removed, ice crystal formation during storage is not the same concern as with solution. This is why lyophilized biologics are used in situations where cold-chain is unreliable.
However, several caveats apply:
- Once reconstituted with bacteriostatic water, the product becomes an aqueous solution and the same freezing risks apply as any other solution.
- Lyophilized powder still has specified storage conditions. Moisture ingress, light, and temperature can degrade the powder through different pathways (oxidation, solid-state deamidation).
- Compounding pharmacies are required to have stability data supporting their labeled conditions. That data, not general class assumptions, governs what is safe for a specific product.
- There is no FDA-approved lyophilized semaglutide product as of 2026. Any lyophilized semaglutide is a compounded product, and quality varies with the compounding pharmacy's practices.
Freezing vs. heat damage: how do they compare?
| Factor | Freezing (below 32 F / 0 C) | Heat (above label limit) |
|---|---|---|
| Primary damage mechanism | Ice crystal mechanical disruption; freeze concentration; pH excursion | Hydrolysis; oxidation; thermal unfolding |
| Fatty-acid linker impact | Conformation disruption via aggregation | Chemical hydrolysis of ester/amide bonds over time |
| Reversible? | No | No |
| Visible to the eye? | Sometimes (cloudiness, particles), but sub-visible aggregates are common | Sometimes (color change to yellow/amber in severe cases), often invisible early |
| Speed of damage | Can occur within minutes of freezing | Slower at moderate temperatures; accelerates significantly above 77 F |
| FDA label rule | Do not freeze; discard if frozen | Discard if exposed to temperatures above labeled limit for extended periods; specific rules per product |
| Most common real-world scenario | Back of refrigerator cold spot; winter shipping; forgotten vial in car overnight in cold weather | Left in car in summer; exposed to direct sunlight; stored near a heat source |
Both damage types are serious. Neither can be corrected. The honest answer is that freezing gets somewhat less attention in patient education than heat does, which is a gap given that refrigerator cold spots are a common, underappreciated exposure route.
Operational checklist: reading labels and handling cold-chain failures
Reading the label/COA for compounded semaglutide:
- Look for explicit temperature range (should specify a lower bound above 32 F / 0 C, typically 36 to 46 F / 2 to 8 C).
- Check whether the product is solution or lyophilized powder, as they have different handling rules.
- Note the beyond-use date. Cold-chain failure events do not reset the clock; they end it.
- Confirm the formulation notes the excipient (bacteriostatic water with benzyl alcohol, sterile water, or other). This matters for reconstitution and storage once opened.
Shipping event: what to do step by step:
- Record the approximate time and temperature the product was exposed to (if known from a cold pack or shipper's temperature log).
- Inspect the vial: look for cloudiness, particles, frost, color change.
- If any visual abnormality: discard immediately.
- If visually clear but a freezing event is suspected or confirmed: discard. Do not inject.
- Contact the compounding pharmacy or Novo Nordisk patient services to report the event and arrange replacement if covered.
- Document the batch/lot number before discarding so the pharmacy can investigate if needed.
Reconstitution note for lyophilized compounded semaglutide: Use only the diluent specified by the pharmacy (typically bacteriostatic water for injection). Mix gently; do not shake. Shaking a reconstituted peptide can also induce aggregation through a different mechanical pathway (air-water interface shear). Store reconstituted solution per the pharmacy label, refrigerated, and never freeze it.
Frequently Asked Questions
Can semaglutide freeze?
No. Semaglutide solution should never be frozen. Freezing can denature the peptide structure, cause aggregation, and destroy the albumin-binding fatty-acid chain that gives semaglutide its long half-life. Ozempic, Wegovy, and compounded semaglutide vials all carry explicit do-not-freeze labeling.
What happens to semaglutide if it freezes?
Ice crystal formation can physically disrupt the peptide's 3D conformation and cause protein aggregation. The C18 fatty-acid linker that anchors semaglutide to albumin is sensitive to freeze-thaw stress. The result is reduced potency, potential for particulate matter, and an unknown immunogenicity risk from aggregated protein.
Can you use semaglutide after it has been frozen?
No. Both Novo Nordisk and FDA-approved prescribing information state that frozen semaglutide must be discarded. You cannot reliably assess potency loss with the naked eye, and injecting degraded or aggregated peptide carries unknown safety risks.
What is the correct storage temperature for semaglutide?
Unopened semaglutide pens or vials should be stored at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius) in the refrigerator. After first use, Ozempic pens can be stored at room temperature up to 77 F / 25 C for up to 56 days. Compounded vials follow the compounding pharmacy's label, typically refrigerated throughout.
How can I tell if my semaglutide has been frozen?
Look for visible particles, cloudiness, or a color change from clear to milky or yellow. Frost inside the vial cap or a previously frozen appearance are red flags. However, aggregation can occur without visible changes, so when in doubt, discard.
Does freezing destroy semaglutide immediately?
Not necessarily instantaneously. Brief, borderline-temperature excursions near 32 F (0 C) may cause partial or minimal damage depending on duration and rate of cooling. However, confirmed freezing events should always result in discarding the product because potency loss cannot be quantified without lab testing.
What should I do if semaglutide was left in a cold car or mailbox overnight?
Check the vial or pen for particles, cloudiness, and color changes. If any are present, discard. If the solution looks clear but freezing is suspected, contact the prescribing provider or compounding pharmacy. Most pharmacies and Novo Nordisk patient services can advise on replacement.
Can lyophilized (powder) semaglutide be frozen?
Lyophilized compounded semaglutide powder is generally more freeze-stable than reconstituted solution because water content is minimal. However, specific storage conditions are set by the compounding pharmacy's stability data. Always follow the label; do not assume powder can be frozen without explicit guidance.
Why do refrigerators sometimes freeze semaglutide near the back wall?
Household refrigerators have cold spots near the evaporator coil, typically at the back wall or directly beneath freezer vents. Temperatures there can drop below 32 F even when the thermostat reads 38 F. Store semaglutide on a middle shelf toward the front, away from walls and vents.
Is there any way to recover potency after semaglutide freezes?
No. There is no known method to reverse freeze-induced aggregation or denaturation in a peptide solution at home. Re-dissolving aggregated protein does not restore native conformation. Discard and replace.
Does heat damage semaglutide the same way freezing does?
Heat above the labeled limit also degrades semaglutide, primarily through hydrolysis and thermal unfolding. Both extremes are harmful, but the mechanisms differ. Ice crystal damage is mechanical and structural; heat damage is primarily chemical. Neither is reversible.
What does FDA labeling say about freezing semaglutide?
The FDA-approved prescribing information for Ozempic (semaglutide injection) explicitly states: "Do not freeze. Do not use if it has been frozen." The same instruction appears in the Wegovy prescribing information. This is a hard discard rule, not a caution.
Sources
- Novo Nordisk. Ozempic (semaglutide injection) U.S. Prescribing Information. FDA. Revised 2023. Accessed via FDA.gov.
- Novo Nordisk. Wegovy (semaglutide injection) U.S. Prescribing Information. FDA. Revised 2023. Accessed via FDA.gov.
- Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. Journal of Pharmacy and Pharmacology. 2010;62(11):1607-1621. (Referenced for general formulation stability context.)
- Carpenter JF, Pikal MJ, Chang BS, Randolph TW. Rational design of stable lyophilized protein formulations: some practical advice. Pharmaceutical Research. 1997;14(8):969-975.
- Kerwin BA. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. Journal of Pharmaceutical Sciences. 2008;97(8):2924-2935.
- United States Pharmacopeia. General Chapter 1 (Injections and Implanted Drug Products); General Chapter 789 (Particulate Matter in Ophthalmic Solutions, referenced for particulate matter methodology context). USP-NF.
- Drucker DJ. The biology of incretin hormones. Cell Metabolism. 2006;3(3):153-165. (Background on GLP-1 receptor agonist mechanism.)
- Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2016;375(19):1834-1844. (SUSTAIN-6 trial; referenced for clinical context.)
- Lau J, et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015;58(18):7370-7380. (Source for structural/chemical description including C18 fatty-acid linker and albumin binding.)
- Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999;185(2):129-188.
Footer Disclaimers
Platform: FormBlends provides educational and informational content about peptides and compounded medications. This page does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or modifying any medication or treatment protocol.
Research Compound / Compounded Medication: Compounded semaglutide is not an FDA-approved drug product. It is produced by licensed compounding pharmacies under the oversight of state boards of pharmacy and, for 503B outsourcing facilities, FDA. It is distinct from Ozempic and Wegovy. Quality, purity, and stability may vary by compounder. The information on this page about compounded semaglutide reflects general principles and should not be taken as an endorsement of any specific compounding pharmacy.
Results: Individual responses to any medication vary. No outcomes are guaranteed. Storage failures (freezing, heat exposure) may render a product ineffective or unsafe regardless of the dose or protocol used.
Trademark: Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S. FormBlends has no affiliation with Novo Nordisk. Trademark names are used solely for reference and identification purposes.